MyAverix Finance
US · Healthcare
First Tracks Biotherapeutics (TRAX)
Biotechnology
First Tracks Biotherapeutics (TRAX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-22, reported market cap is $554.09M, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for TRAX
First Tracks Biotherapeutics (TRAX) — FAQ
What is First Tracks Biotherapeutics's market cap?
First Tracks Biotherapeutics (TRAX) has a reported market cap of $554.09M (data as of 2026-05-22).
What is TRAX's P/E ratio?
The price-to-earnings (P/E) ratio for First Tracks Biotherapeutics (TRAX) is 25.00 (data as of 2026-05-22).
Does First Tracks Biotherapeutics pay a dividend?
Dividend yield is not available in the current snapshot for First Tracks Biotherapeutics (TRAX). Check the MyAverix Finance app for the latest dividend data.
What sector is First Tracks Biotherapeutics in?
First Tracks Biotherapeutics (TRAX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is TRAX listed on?
TRAX is listed on US.
What is First Tracks Biotherapeutics's net margin?
First Tracks Biotherapeutics (TRAX) reports a net margin of 0.0% (data as of 2026-05-22).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.